Evaluation of Dietary Supplements with Claims of Antimicrobial Activity

Journal of Infectious Disease Pharmacotherapy

Volumn 6, Issue 3, 2003, Pages 1-29

  Klepser, Teresa Bailey ^a   Berryhill, Brian ^b   Dixon, Kristine ^a   McGinnis, Mitzi M ^a   Mulholland, Stacey ^a   Pomeroy, Sara ^a  

^a FERRIS STATE UNIVERSITY   (United States)

^b SPECTRUM HEALTH   (United States)

Author keywords

Antimicrobial; Dietary supplements; Interaction

Indexed keywords

ALLICIN; ALLIIN; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BISMUTH SALICYLATE; CYANOCOBALAMIN; ECHINACEA EXTRACT; ERICACEAE VACCINIUM EXTRACT; GARLIC EXTRACT; HIPPURIC ACID; OXALIC ACID; PLANT EXTRACT; PROTON PUMP INHIBITOR; TEA TREE OIL; TERPINEN 4 OL; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ALLERGIC REACTION; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; CLINICAL TRIAL; CRANBERRY; DIARRHEA; DIET SUPPLEMENTATION; DIZZINESS; DRUG MECHANISM; DRUG POTENCY; ECHINACEA; ERADICATION THERAPY; ERICACEAE VACCINIUM; EVALUATION; FEVER; FLATULENCE; GARLIC; HALITOSIS; HEARTBURN; HUMAN; HYPERSENSITIVITY REACTION; LINGONBERRY; MYCOSIS; NAUSEA; NEPHROLITHIASIS; NONHUMAN; REVIEW; SAFETY; SKIN IRRITATION; SKIN TOXICITY; SWEATING; VOMITING;

EID: 1442305208     PISSN: 10687777     EISSN: None     Source Type: Journal    
DOI: 10.1300/J100v06n03_01     Document Type: Review

References (80)

1. Cranberry: Science backs folk remedy for urinary tract infections. Envir Nutr 1999;22(6):8.
2. Bennett J, Brown C. Use of herbal remedies by patients in a health maintenance organization. Journal Amer Pharm Assoc 2000;40(3):353-8.
3. Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections. (Cochrane Review). In: The Cochrane Library, Issue 4, 2001. Oxford: Update Software.
4. Hooton T, Stamm W. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am 1991;75(2):339-57.
5. Kerr K. Cranberry juice and prevention of recurrent urinary tract infection. Lancet 1999;353(9153):673.
6. Harkins K. What's the use of cranberry juice? Age and Aging 2000;29:9-12.
7. Kahn H, Panariello V, Saeli J, et al. Implications for therapy of urinary tract infection and calculi: Effect of cranberry juice on urine. Jour of Amer Diet Assoc 1967;51:251-4.
8. Sobota AE. Inhibition of bacterial adherence by cranberry juice: Potential use for the treatment of urinary tract infections. J Urol. 1984 May; 131(5):1013-6.
9. Nazarko L. The therapeutic uses of cranberry juice. Nursing Standard 1995; 9(34):33-5.
10. Ahuja S, Kaack B, Roberts J. Loss of fimbrial adhesion with the addition of Vaccinum macrocarpon to the growth medium of P-Fimbriated Escherchia coli. J Urol 1998;159(2):559-62.
11. Howell A, Vorsa N, Der Marderosian A, Foo L. Inhibition of the adherence of P-Fimbriated Escherchia coli to uropepithelial cell surfaces by proanthocyanidin extracts from cranberries. New Eng J Med 1998;339(15):1085-6.
12. Natural Medicines Comprehensive Database. Cranberry. 〈 http://www.naturakkuabase.com/monograph〉. Accessed January 9, 2002.
13. Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57:26-9.
14. LaValle J, Krinksy D, Hawkins E, Pelton R, Willis N. Natural Therapeutics Pocket Guide. Hudson, OH. Lexi-Comp, 2001.
15. Professional's Handbook of Complementary & Alternative Medicines, edited by C.W. Fetrow and Juan R. Avila. Springhouse, PA. Springhouse Corporation, 2001.
16. Rotblatt M. Cranberry, feverfew, horse chestnut and kava. West J Med 1999; 171(3):195-8.
17. Gardiner P, Wornham W. Recent review of complementary and alternative medicine used by adolescents. Curr Opin Pediatr 2000;12(4):298-302.
18. Foda MM, Middlebrook PF, Gatfield CT, et al. Efficacy of cranberry in prevention of urinary tract infection in a susceptible pediatric population. Can J Urol 1995;2(1):98-102.
19. Schlager TA, Anderson S, Trudell J, et al. Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization. J Pediatr 2000;135(6):698-702.
20. Avorn J, Monane M, Gurwitz J, Glynn R, Choodnovsky T, Lipsitz L. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994;271(10):751-4.
21. Walker E, Barney D, Mickelsen J. Cranberry concentrate: UTI prophylaxis. J Fam Pract 1997;45(2):167-8.
22. Kontiokari T, Sundqvist K, Nuvtinen M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001;322:1-5.
23. Triezenberg D. Can regular intake of either cranberry juice of a drink containing Lactobacillus bacteria prevent urinary tract infection (UTI) recurrence in women after an initial episode? J Fam Pract 2001;50(10):841.
24. Hobbs C. Echinacea: A literature review-botany, history, chemistry, pharmacology, toxicology, and clinical uses. Special supplement to HerbalGram #30, 1994.
25. Combest WL, Nemecz G. Echinacea: This rediscovered American herb has shown efficacy as an important natural immune-system stimulator. US Pharm 1997; Oct:126-132.
26. Dr. James Downey's Herbal Research & Healing: The Future's Medicine Today. http://www.herbsinfo.com/pages.echin.htm accessed on June 6, 1997.
27. Roesler J, Steinmuller C, Kiderlen A, et al. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. Int J Immunopharmacol 1991;13(1):27-37.
28. Binns SE, Purgina B, Bergeron C, et al. Light-mediated antifungal activity of Echinacea extracts. Planta Medica 2000;66:241-4.
29. Barrett B, Vohmann M, Calabresse C. Echinacea for upper respiratory infection. J Fam Pract 1999;48:628-35.
30. Hoffman HL, Ernst EJ, Redford TW, Klepser ME. Effect of CpG DNA oligodeoxynucleotides and Echinacea on the fungicidal activity of amphotericin B in a disseminated murine Candidal infection model. J Infect Dis Pharmacotherapy 2001; 4(4):55-66.
31. Henneicke-von Zepeli HH, Hentschel C, Scnitker J, Kohnen R, Kõhler G, Wûstenberg P. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): Results of a randomized, double-blind, placebo-controlled, multicenter study. Curr Med Res Opinion 1999;15(3):214-27.
32. Lindemuth GF, Lindenmuth EB. The efficacy of Echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: A randomized, double-blind placebo-controlled study. J Altern Complem Med 2000; 6(4):327-34.
33. Turner RB, Riker DK, Gangemi JD. Ineffectiveness of Echinacea for prevention of experimental rhinovirus colds. Antimicrobial Agents Chemotherapy 2000; 6:1708-9.
34. Berman S, See DM, See JR, et al. Dramatic increase in immune mediated HIV killing activity induced by Echinacea angustifolia. Abstract only. http://www.abstracts-on-line.com/scripts/abstracts/aids/AIDS.cfm/48731138 accessed on November 23, 1999.
35. Gallo M, Sarkar M, Au W, et al. Pregnancy outcome following gestational exposure to Echinacea. Arch Intern Med 2000;160:3141-3.
36. Jellin J. Echinacea. In: Natural Medicines Comprehensive Database. Therapeutic Research Faculty. Stockton, CA, 1999.
37. Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies. Am J Health-Syst Pharm 1999;56:125-38.
38. Jellin J. Garlic. In: Natural Medicines Comprehensive Database. Therapeutic Research Faculty. Stockton, CA, 2000.
39. Buhmer SH. Herbal Antibiotics: Natural Alternatives for Treating Drug-Resistant Bacteria. Pownal, VT: Storey Books, 1999; 33-66.
40. Sivam GP. Recent advances on the nutritional effects associated with the use of garlic as a supplement: Protection against Helicobacter pylori and other bacterial infections by garlic. Amer Soc Nutr Sci 2001:1106s-8s.
41. Anki S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes and Infection 1999;2:125-9.
42. Tyler VE. Garlic and other alliums. The Honest Herbal. Pharmaceutical Products Press, 1992; 139-43.
43. The Review of Natural Products. St. Louis: Facts and Comparisons, 1997.
44. Reuter HD. Allium sativum and Allium ursinum: Part 2. Pharmacology and medicinal application. Phytomedicine 1995;2:73-91.
45. Elnima EI, Ahmed SA, Mekkawi AG, et al. The antimicrobial activity of garlic and onion extracts. Pharmazie 1983;38:747-8.
46. Tsao SM, Yin MC. In vitro antimicrobial activity of four diallyl sulfides occurring naturally in garlic and chinese leek oils. J Med Microbiol 2001;50:646-9.
47. Naganawa R, Iwata N, Ishikawa K, et al. Inhibition of microbial growth by ajone, a sulfur-containing compound derived from garlic. Applied and Environmental Microbiology 1996;62:4238-42.
48. Gowsala PS, Lampe JW, Ulness B, et al. Helicobacter pylori-in vitro susceptibility to garlic (Allium sativum) extract. Nutrition and Cancer 1997;27:118-21.
49. O'Gara EA, Hill DJ, Maslin DJ. Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Applied and Environmental Microbiology 2000;66:2269-73.
50. Yoshida S, Kasuga S, Hayashi N, et al. Antifungal activity of ajoene derived from garlic. Applied and Environmental Microbiology 1987;53:615-7.
51. Shen J, Davis LE, Wallace JM, et al. Enhanced diallyl trisulfide has in vitro synergy with amphotericin B against Cryptococcus neoformans. Planta Medica 1996; 62:415-8.
52. Sivam GP, Lampe JW, Ulness B, Swanzy SR, Potter JR. Helicobacter pylori-in vitro susceptibility to garlic (Allium sativum) extract. Nutr and Cancer 1997;27(2):18-21.
53. Davis LE, Shen J, Royer RE. In vitro synergism of concentrated Allium satium extract and amphotericin B against Cryptococcus neoformans. Planta Medica 1994; 60:546-9.
54. Amer M, Taha M, Tosson Z. The effect of aqueous garlic extract on the growth of dermatophytes. Int Soc Trop Derm 1979;285-7.
55. Prasad G, Sharma VD, Kumar A. Efficacy of garlic (Allium sativum L.) therapy against experimental dermatophytosis in rabbits. Indian J Med Res 1982;75:465-7.
56. Weber ND, Andersen DO, North JA, et al. In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Med 1992;58:417-23.
57. You WC, Zhang L, Gail MH, et al. Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer. Int J Epidemiol 1998;27(6):941-4.
58. McNulty CA, Wilson MP, Havinga W, Johnston B, O'Gara EA, Maslin DJ. A pilot study to determine the effectiveness of garlic oil capsules in the treatment of dyspeptic patients with Helicobacter pylori. Helicobacter 2001;6(3):249-53.
59. Graham DY, Anderson SY, Lang T. Garlic or jalapeno peppers for treatment of Helicobacter pylori infection. Am J Gastroenterol 1999;94(5):1200-2.
60. Tyler VE. Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York: The Haworth Press, 1994.
61. Newall CA, Anderson LA, Philpson JD. Herbal Medicine: A Guide for Healthcare Professionals. London, UK: The Pharamaceutical Press, 1996.
62. Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.
63. Carson CF, Riley TV, Cookson BD. Efficacy and safety of tea tree oil as a topical antimicrobial agent. J Hosp Infect 1998;40:175-8.
64. Cristoph F, Kaulfers PM, Stahl-Biskup. A comparative study of the in vitro antimicrobial activity of tea tree oils s.l. with special reference to the activity of beta-triketones. Planta Med 2000;66(6):556-60.
65. Allen P. Tea tree oil: The science behind the antimicrobial hype. Lancet 2001;358(9289):1245.
66. Cox SD, Gustafson JE, Mann CM, et al. Tea tree oil causes K+ leakage and inhibits respiration in Escherichia coli. Lett Appl Microbio 1998;26(5):355-8.
67. May J, Chan CH, King A, et al. Time-kill of tea tree oils on clinical isolates. J Antimicrob Chemother 2000;45:639-43.
68. Cox SD, Mann CM, Markham JL, et al. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol 2000;88:170-5.
69. Chan CH, Loudon. Activity of tea tree oil on methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1988;39(3):244-5.
70. Hammer KA, Carson CF, Riley TV. Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am J Infect Control 1996;24:186-9.
71. Elsom GK, Hide D. Susceptibility of methicillin-resistant Staphylococcus aureus to tea tree oil and mupirocin. J Antimicrob Chemother 1999;43(3):427-8.
72. Nelson RR. Selection of resistance to the essential oil of Melaleuca alternifolia in Staphylococcus aureus. Antimicrob Agents Chemother 2000;45:549-50.
73. Sherry E, Boeck H, Warnke PH. Percutaneous treatment of chronic MRSA osteomyelitis with a novel plant-derived antiseptic. BMC Surgery 2001;1:1.
74. Caelli M, Porteous J, Carson CF, et al. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infec 2000;46:236-7.
75. Hammer KA, Carson CF, Riley TV. In vitro susceptibilities of Lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil. Antimicrob Agents Chemother 1999;43:196.
76. Arweiler NB, Donos N, Netuschil L, et al. Clinical and antibacterial effect of tea tree oil-a pilot study. Clin Oral Invest 2000;4:70-3.
77. Hammer KA, Carson CF, Riley TV. In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species. Antimicrob Agents Chemother 2000;44(2):467-9.
78. Hammer KA, Carson CF, Riley TV. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J Antimicrob Chemother 1998;42:591-5.
79. Williamson JS, Wyandt CM. The herbal generation: Trends, products, and pharmacy's role. Drug Topics 1999 April 5;8:69-78.
80. Miller LG, Hume A, Harris IM, et al. White paper on herbal products. Pharmacotherapy 2000;20(7):877-91.